Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

November 20, 2022

Study Completion Date

November 30, 2022

Conditions

Prostate Cancer (Diagnosis)Prostate-specific Membrane AntigenPositron Emission Tomography (PET)

Interventions

DIAGNOSTIC_TEST

PSMA PET/CT scan

Different developing agents

DIAGNOSTIC_TEST

FDG-PET

Different developing agents

Trial Locations (1)

Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang

All Listed Sponsors

lead

Jiequn Yu

OTHER